• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病患者尿白蛋白相关的循环外泌体 microRNAs。

The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy.

机构信息

Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, South Korea.

Hyonam Kidney Laboratory, Soonchunhyang University Seoul Hospital, 59 Daesagwan-ro, Youngsan-gu, Seoul, South Korea.

出版信息

J Transl Med. 2019 Jul 22;17(1):236. doi: 10.1186/s12967-019-1983-3.

DOI:10.1186/s12967-019-1983-3
PMID:31331349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6647278/
Abstract

BACKGROUND

Diabetic nephropathy (DN) is associated with high risk of cardiovascular disease and mortality. Exosomal microRNAs (miRNAs) regulate gene expression in a variety of tissues and play important roles in the pathology of various diseases. We hypothesized that the exosomal miRNA profile would differ between DN patients and patients without nephropathy.

METHODS

We prospectively enrolled 74 participants, including healthy volunteers (HVs), diabetic patients without nephropathy, and those with DN. The serum exosomal miRNA profiles of participants were examined using RNA sequencing.

RESULTS

The expression levels of 107 miRNAs differed between HVs and patients without DN, whereas the expression levels of 95 miRNAs differed between HVs and patients with DN. Among these miRNAs, we found 7 miRNAs (miR-1246, miR-642a-3p, let-7c-5p, miR-1255b-5p, let-7i-3p, miR-5010-5p, miR-150-3p) that were uniquely up-regulated in DN patients compared to HVs, and miR-4449 that was highly expressed in DN patients compared to patients without DN. A pathway analysis revealed that these eight miRNAs are likely involved in MAPK signaling, integrin function in angiogenesis, and regulation of the AP-1 transcription factor. Moreover, they were all significantly correlated with the degree of albuminuria.

CONCLUSIONS

Patients with DN have a different serum exosomal miRNA profile compared to HVs. These miRNAs may be promising candidates for the diagnosis and treatment of DN and cardiovascular disease.

摘要

背景

糖尿病肾病(DN)与心血管疾病和死亡率的高风险相关。外泌体 microRNAs(miRNAs)在多种组织中调节基因表达,在各种疾病的病理中发挥重要作用。我们假设 DN 患者与无肾病患者的外泌体 miRNA 谱不同。

方法

我们前瞻性地招募了 74 名参与者,包括健康志愿者(HV)、无肾病的糖尿病患者和 DN 患者。使用 RNA 测序检查参与者的血清外泌体 miRNA 谱。

结果

HV 与无肾病患者之间的表达水平有 107 个 miRNAs 不同,HV 与 DN 患者之间的表达水平有 95 个 miRNAs 不同。在这些 miRNAs 中,我们发现 7 个 miRNAs(miR-1246、miR-642a-3p、let-7c-5p、miR-1255b-5p、let-7i-3p、miR-5010-5p、miR-150-3p)在 DN 患者中与 HV 相比特异性上调,miR-4449 在 DN 患者中与无肾病患者相比高度表达。通路分析表明,这 8 个 miRNAs 可能参与 MAPK 信号、血管生成中的整合素功能和 AP-1 转录因子的调节。此外,它们都与白蛋白尿程度显著相关。

结论

与 HV 相比,DN 患者的血清外泌体 miRNA 谱不同。这些 miRNAs 可能是 DN 和心血管疾病诊断和治疗的有前途的候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/6647278/903fceee3500/12967_2019_1983_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/6647278/6edf82f24dd3/12967_2019_1983_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/6647278/0a3624cb6fed/12967_2019_1983_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/6647278/903fceee3500/12967_2019_1983_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/6647278/6edf82f24dd3/12967_2019_1983_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/6647278/0a3624cb6fed/12967_2019_1983_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c91d/6647278/903fceee3500/12967_2019_1983_Fig3_HTML.jpg

相似文献

1
The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy.糖尿病肾病患者尿白蛋白相关的循环外泌体 microRNAs。
J Transl Med. 2019 Jul 22;17(1):236. doi: 10.1186/s12967-019-1983-3.
2
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.2型糖尿病肾病患者尿液外泌体微小RNA特征
PLoS One. 2016 Mar 1;11(3):e0150154. doi: 10.1371/journal.pone.0150154. eCollection 2016.
3
Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.循环外泌体 miRNA 作为稳定型冠状动脉疾病的新型生物标志物。
Biomed Res Int. 2020 Dec 11;2020:3593962. doi: 10.1155/2020/3593962. eCollection 2020.
4
Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy.尿外泌体源性let-7c-5p在II型糖尿病肾病诊断及病情进展中的潜在价值
Clin Lab. 2018 May 1;64(5):709-718. doi: 10.7754/Clin.Lab.2018.171031.
5
Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.血浆 microRNAs 在糖尿病肾病中的表达谱分析及临床意义。
J Diabetes Res. 2019 May 14;2019:5204394. doi: 10.1155/2019/5204394. eCollection 2019.
6
Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer.近端肾小管来源的外泌体通过 miR-92a-1-5p 转移促进糖尿病肾病系膜细胞损伤。
Cell Commun Signal. 2023 Jan 13;21(1):10. doi: 10.1186/s12964-022-00997-y.
7
Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.一种新型尿液微小RNA组合(133b、-342和-30)作为糖尿病肾病生物标志物的临床验证:通过生物信息学分析确定
Biomed Pharmacother. 2016 Oct;83:92-99. doi: 10.1016/j.biopha.2016.06.018. Epub 2016 Jun 23.
8
miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy.2 型糖尿病肾病患者中的 miR-21-3p 和 miR-192-5p。
Diagnosis (Berl). 2022 Aug 18;9(4):499-507. doi: 10.1515/dx-2022-0036. eCollection 2022 Nov 1.
9
Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.干细胞衍生和循环的外泌体 microRNAs 作为糖尿病肾病管理的新潜在工具。
Stem Cell Res Ther. 2022 Jan 24;13(1):25. doi: 10.1186/s13287-021-02696-w.
10
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.从血清外泌体 microRNAs 中鉴定慢性萎缩性胃炎的非侵入性生物标志物。
BMC Cancer. 2019 Feb 8;19(1):129. doi: 10.1186/s12885-019-5328-7.

引用本文的文献

1
New role for an old acquaintance: miR-1246 as a new inflammatory and prognostic marker in polytrauma patients.老相识的新角色:miR-1246作为多发伤患者新的炎症和预后标志物
PeerJ. 2025 Apr 7;13:e19185. doi: 10.7717/peerj.19185. eCollection 2025.
2
Research progress on small extracellular vesicles in diabetic nephropathy.糖尿病肾病中小细胞外囊泡的研究进展
Front Cell Dev Biol. 2025 Mar 5;13:1535249. doi: 10.3389/fcell.2025.1535249. eCollection 2025.
3
The role of exosomes in the pathogenesis and management of diabetic kidney disease: a systematic review and meta-analysis.

本文引用的文献

1
Bariatric Surgery Alters microRNA Content of Circulating Exosomes in Patients with Obesity.肥胖症患者的减肥手术改变了循环外泌体中的 microRNA 含量。
Obesity (Silver Spring). 2019 Feb;27(2):264-271. doi: 10.1002/oby.22379. Epub 2019 Jan 9.
2
Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.糖尿病肾病中miR-31的下调及其与炎症的关系
Cell Physiol Biochem. 2018;50(3):1005-1014. doi: 10.1159/000494485. Epub 2018 Oct 24.
3
Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease.
外泌体在糖尿病肾病发病机制及治疗中的作用:一项系统综述和荟萃分析
Front Endocrinol (Lausanne). 2024 Dec 3;15:1398382. doi: 10.3389/fendo.2024.1398382. eCollection 2024.
4
Role of Extracellular Vesicle-Derived Noncoding RNAs in Diabetic Kidney Disease.细胞外囊泡衍生的非编码RNA在糖尿病肾病中的作用
Kidney Dis (Basel). 2024 Apr 26;10(4):303-312. doi: 10.1159/000539024. eCollection 2024 Aug.
5
A Systematic Review and Meta-Analysis of microRNA Profiling Studies in Chronic Kidney Diseases.慢性肾脏病中微小RNA谱研究的系统评价与荟萃分析
Noncoding RNA. 2024 May 3;10(3):30. doi: 10.3390/ncrna10030030.
6
Evolution and global research trends of immunity in diabetic nephropathy: a bibliometric and visual analysis from 2004 to 2023.免疫在糖尿病肾病中的作用的演变和全球研究趋势:2004 年至 2023 年的文献计量和可视化分析。
Int Urol Nephrol. 2024 Oct;56(10):3307-3321. doi: 10.1007/s11255-024-04081-x. Epub 2024 May 17.
7
Understanding the Roles of Non-coding RNAs and Exosomal Non-Coding RNAs in Diabetic Nephropathy.了解非编码RNA和外泌体非编码RNA在糖尿病肾病中的作用。
Curr Mol Med. 2024 Apr 5. doi: 10.2174/0115665240287631240321072504.
8
MicroRNA-5010-5p ameliorates high-glucose induced inflammation in renal tubular epithelial cells by modulating the expression of PPP2R2D.miR-5010-5p 通过调控 PPP2R2D 的表达改善高糖诱导的肾小管上皮细胞炎症反应。
BMJ Open Diabetes Res Care. 2024 Mar 4;12(2):e003784. doi: 10.1136/bmjdrc-2023-003784.
9
Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.IgA 肾病尿外泌体 miRNA 特征:一项病例对照研究。
Sci Rep. 2023 Dec 4;13(1):21400. doi: 10.1038/s41598-023-47751-z.
10
The Role of Intravesicular Proteins and the Protein Corona of Extracellular Vesicles in the Development of Drug-Induced Polyneuropathy.膀胱内蛋白质和细胞外囊泡的蛋白质冠层在药物性多发性神经病发生中的作用
Curr Issues Mol Biol. 2023 Apr 7;45(4):3302-3314. doi: 10.3390/cimb45040216.
非编码RNA作为早期糖尿病肾病的治疗靶点
Kidney Res Clin Pract. 2018 Sep;37(3):197-209. doi: 10.23876/j.krcp.2018.37.3.197. Epub 2018 Sep 30.
4
MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the 'Asian Indian phenotype'.尿细胞外囊泡中的 microRNAs 是 2 型糖尿病“亚洲印度表型”患者糖尿病肾病的非侵入性早期生物标志物。
Diabetes Metab. 2019 Jun;45(3):276-285. doi: 10.1016/j.diabet.2018.08.004. Epub 2018 Aug 27.
5
MicroRNA and Microvascular Complications of Diabetes.微小RNA与糖尿病微血管并发症
Int J Endocrinol. 2018 Mar 7;2018:6890501. doi: 10.1155/2018/6890501. eCollection 2018.
6
Olfactory receptors are expressed in pancreatic β-cells and promote glucose-stimulated insulin secretion.嗅觉受体在胰腺β细胞中表达,并促进葡萄糖刺激的胰岛素分泌。
Sci Rep. 2018 Jan 24;8(1):1499. doi: 10.1038/s41598-018-19765-5.
7
Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.循环 miRNA 的检测:前列腺癌患者全血浆中外泌体结合 miRNA 和无细胞游离 miRNA 的比较分析。
BMC Cancer. 2017 Nov 9;17(1):730. doi: 10.1186/s12885-017-3737-z.
8
Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity.脂肪组织巨噬细胞衍生的外泌体 miRNA 可以调节体内和体外的胰岛素敏感性。
Cell. 2017 Oct 5;171(2):372-384.e12. doi: 10.1016/j.cell.2017.08.035. Epub 2017 Sep 21.
9
Liraglutide and Renal Outcomes in Type 2 Diabetes.利拉鲁肽与 2 型糖尿病患者的肾脏结局。
N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.
10
Diabetic Kidney Disease: Challenges, Progress, and Possibilities.糖尿病肾病:挑战、进展与可能。
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045. doi: 10.2215/CJN.11491116. Epub 2017 May 18.